Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

RODGER K GARRETT

Allopathic & Osteopathic Physicians Anesthesiology Pain Medicine

NPI
1679560536
CMS profile
166826
Location
PENSACOLA, FL

General Payments · PY2018–2024

$3,880.99

  • Reported across 125 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$910.44

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Travel and Lodging $492.10 2
Food and Beverage $418.34 11

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Medtronic, Inc. $595.86 4
Integra LifeSciences Corporation $143.74 1
Collegium Pharmaceutical, Inc. $80.27 4
Nevro Corp. $41.80 1
Valinor Pharma, LLC $32.48 2
SCILEX PHARMACEUTICALS INC. $16.29 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,543.41 36
PY2019 $323.99 23
PY2020 $161.59 8
PY2021 $250.58 13
PY2022 $405.03 20
PY2023 $285.95 12
PY2024 $910.44 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Collegium Pharmaceutical, Inc. $15.26 02/28/2024 Food and Beverage Undisputed 01/23/2026 1135224223 CMS
Collegium Pharmaceutical, Inc. $20.63 04/22/2024 Food and Beverage Undisputed 01/23/2026 1135243933 CMS
Collegium Pharmaceutical, Inc. $21.43 06/24/2024 Food and Beverage Undisputed 01/23/2026 1135269167 CMS
Collegium Pharmaceutical, Inc. $22.95 08/12/2024 Food and Beverage Undisputed 01/23/2026 1135286912 CMS
Integra LifeSciences Corporation $143.74 04/18/2024 Food and Beverage Undisputed 01/23/2026 1140129362 CMS
Medtronic, Inc. $87.06 03/20/2024 Food and Beverage Undisputed 01/23/2026 1119429135 CMS
Medtronic, Inc. $16.70 10/18/2024 Food and Beverage Undisputed 01/23/2026 1119429141 CMS
Medtronic, Inc. $457.85 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1119429137 CMS
Medtronic, Inc. $34.25 11/05/2024 Travel and Lodging Undisputed 01/23/2026 1119429139 CMS
Nevro Corp. $41.80 06/26/2024 Food and Beverage Undisputed 01/23/2026 1130735248 CMS
SCILEX PHARMACEUTICALS INC. $16.29 02/13/2024 Food and Beverage Undisputed 01/23/2026 1136224347 CMS
Valinor Pharma, LLC $13.13 09/19/2024 Food and Beverage Undisputed 01/23/2026 1130827070 CMS
Valinor Pharma, LLC $19.35 10/10/2024 Food and Beverage Undisputed 01/23/2026 1130827072 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.